Andrea Dotti , Onofrio Lostia , Ivo A. Rubino , Giuseppe Bersant , Luciana Carilli , Domenico Zorretta
{"title":"接受抗精神病药物治疗患者的催乳素反应。癸酸氟非那嗪的作用","authors":"Andrea Dotti , Onofrio Lostia , Ivo A. Rubino , Giuseppe Bersant , Luciana Carilli , Domenico Zorretta","doi":"10.1016/0364-7722(81)90007-2","DOIUrl":null,"url":null,"abstract":"<div><p></p><ul><li><span>1.</span><span><p>1. Fluphenazine decanoate (FD) 50 mg was administered to 15 patients. The patient population was divided into three groups: i) Group A including 5 subjects who had never been treated before; ii) Group B including 5 subjects treated with neuroleptics for at least one year, but who had discontinued the drugs for at least three months and iii) Group C including 5 subjects who had been chronically treated with neuroleptics for at least two years.</p></span></li><li><span>2.</span><span><p>2. The increase in plasma level of the hormone prolactin (PRL) after the administration of FD was different in the three groups. The patients never treated before showed the highest “PRL response”, which had a great variability among all patients.</p></span></li><li><span>3.</span><span><p>3. The “PRL response” did not correlate neither with psychopathological changes nor with extrapyramidal side effects.</p></span></li><li><span>4.</span><span><p>4. The “PRL response” did not seem to be a useful tool in predicting the appropriate dosage and interval of the FD administration in a given patient.</p></span></li></ul></div>","PeriodicalId":20801,"journal":{"name":"Progress in neuro-psychopharmacology","volume":"5 1","pages":"Pages 69-77"},"PeriodicalIF":0.0000,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0364-7722(81)90007-2","citationCount":"6","resultStr":"{\"title\":\"The prolactin response in patients receiving neuroleptic therapy. The effect of fluphenazine decanoate\",\"authors\":\"Andrea Dotti , Onofrio Lostia , Ivo A. Rubino , Giuseppe Bersant , Luciana Carilli , Domenico Zorretta\",\"doi\":\"10.1016/0364-7722(81)90007-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p></p><ul><li><span>1.</span><span><p>1. Fluphenazine decanoate (FD) 50 mg was administered to 15 patients. The patient population was divided into three groups: i) Group A including 5 subjects who had never been treated before; ii) Group B including 5 subjects treated with neuroleptics for at least one year, but who had discontinued the drugs for at least three months and iii) Group C including 5 subjects who had been chronically treated with neuroleptics for at least two years.</p></span></li><li><span>2.</span><span><p>2. The increase in plasma level of the hormone prolactin (PRL) after the administration of FD was different in the three groups. The patients never treated before showed the highest “PRL response”, which had a great variability among all patients.</p></span></li><li><span>3.</span><span><p>3. The “PRL response” did not correlate neither with psychopathological changes nor with extrapyramidal side effects.</p></span></li><li><span>4.</span><span><p>4. The “PRL response” did not seem to be a useful tool in predicting the appropriate dosage and interval of the FD administration in a given patient.</p></span></li></ul></div>\",\"PeriodicalId\":20801,\"journal\":{\"name\":\"Progress in neuro-psychopharmacology\",\"volume\":\"5 1\",\"pages\":\"Pages 69-77\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1981-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/0364-7722(81)90007-2\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Progress in neuro-psychopharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/0364772281900072\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in neuro-psychopharmacology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0364772281900072","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The prolactin response in patients receiving neuroleptic therapy. The effect of fluphenazine decanoate
1.
1. Fluphenazine decanoate (FD) 50 mg was administered to 15 patients. The patient population was divided into three groups: i) Group A including 5 subjects who had never been treated before; ii) Group B including 5 subjects treated with neuroleptics for at least one year, but who had discontinued the drugs for at least three months and iii) Group C including 5 subjects who had been chronically treated with neuroleptics for at least two years.
2.
2. The increase in plasma level of the hormone prolactin (PRL) after the administration of FD was different in the three groups. The patients never treated before showed the highest “PRL response”, which had a great variability among all patients.
3.
3. The “PRL response” did not correlate neither with psychopathological changes nor with extrapyramidal side effects.
4.
4. The “PRL response” did not seem to be a useful tool in predicting the appropriate dosage and interval of the FD administration in a given patient.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
